Biomedical Papers · 2001 · 12 citations · 9 references
PharmacyPharmacokineticsPharmacologyBioavailabilityDrug DeliveryPharmaceutical FormulationBioavailability AnalysisBioavailability ModelingDrug SolubilityFormulation Effects On BioavailabilityNanoparticle FormulationsPhysicochemical Determinants Of BioavailabilityCyclosporine PharmacokineticsDispersionsParticle Size Distribution MeasurementParticle Size MeasurementParticle-size DistributionPharmaceutical Particle SizePharmacokinetic Bioavailability AnalysisPharmacokinetic Parameters
The effect of particle size on bioavailability of 9 different formulations with cyclosporine A was studied. A common feature of all the formulations was the ability to form submicron dispersions under dilution. The composition of individual formulations was chosen in such a way that they were based on same or similar excipients. For each formulation, pharmacokinetic study was carried out in beagle dogs. On groups of 10 dogs, the average AUC was evaluated. Particle size of formulations under dilution in water was measured by laser scattering method. According to the results of particle size measurement, the formulations were sorted out into groups of similar particle size distribution by use of two methods of multivariate statistical analysis. The average AUC within groups and between-groups was compared, and the effect of particle size on bioavailability was evaluated.
9
Comparing Individual Means in the Analysis of Variance
John W. Tukey · Biometrics · 1949 · 4.1K citations
A Method for Judging all Contrasts in the Analysis of Variance
Henry Scheffé · Biometrika · 1953 · 923 citations
Liposomal cyclosporine. Characterization of drug incorporation and interbilayer exchange.
CINDY OUYANG, EDWARD CHOICE, John Holland et al. · PubMed · 1995 · 25 citations